230 related articles for article (PubMed ID: 28599259)
1. Predictive value of cystatin C in people with suspected or established coronary artery disease: A meta-analysis.
Yang S; Song L; Zhao L; Dong P; Lai L; Wang H
Atherosclerosis; 2017 Aug; 263():60-67. PubMed ID: 28599259
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of circulating cystatin C level in patients with acute coronary syndrome: a meta-analysis.
Jin S; Xu J; Shen G; Gu P
Scand J Clin Lab Invest; 2021 Feb; 81(1):1-7. PubMed ID: 33207943
[TBL] [Abstract][Full Text] [Related]
3. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of s-cystatin C for mortality after coronary artery bypass surgery.
Dardashti A; Nozohoor S; Algotsson L; Ederoth P; Bjursten H
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):139-46. PubMed ID: 27056756
[TBL] [Abstract][Full Text] [Related]
5. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study).
Patel D; Ahmad S; Silverman A; Lindsay J
Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273
[TBL] [Abstract][Full Text] [Related]
6. Cystatin C for predicting all-cause mortality and rehospitalization in patients with heart failure: a meta-analysis.
Chen S; Tang Y; Zhou X
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30643006
[TBL] [Abstract][Full Text] [Related]
7. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum uric acid and risk of cardiovascular or all-cause mortality in people with suspected or definite coronary artery disease: A meta-analysis.
Wang R; Song Y; Yan Y; Ding Z
Atherosclerosis; 2016 Nov; 254():193-199. PubMed ID: 27755985
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of β2-microglobulin and cystatin C are associated with left atrial size: additional link between the kidney and the heart.
Liu YS; Wang X; Jiang WD; Huang ZW; Wang YM; Hao L; Xing JL; Wang L; Liu XX; Lounsbury P; Zhang M; Lu QH
Clin Nephrol; 2013 Sep; 80(3):168-76. PubMed ID: 23849305
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention.
Angeli F; Verdecchia P; Savonitto S; Arraiz G; Zaninotto M; Broccatelli A; Cosma C; De Servi S; Sabino F; Briguori C; Ambrosio G; Cavallini C;
EuroIntervention; 2015 Nov; 11(7):757-64. PubMed ID: 25136879
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of cystatin C in patients with acute coronary syndrome: A systematic review and meta-analysis.
Sun Y; Lu Q; Cheng B; Tao X
Eur J Clin Invest; 2021 Mar; 51(3):e13440. PubMed ID: 33128232
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study.
Keller T; Messow CM; Lubos E; Nicaud V; Wild PS; Rupprecht HJ; Bickel C; Tzikas S; Peetz D; Lackner KJ; Tiret L; Münzel TF; Blankenberg S; Schnabel RB
Eur Heart J; 2009 Feb; 30(3):314-20. PubMed ID: 19153178
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate.
Qing X; Furong W; Yunxia L; Jian Z; Xuping W; Ling G
Cardiovasc Diabetol; 2012 Sep; 11():108. PubMed ID: 22978689
[TBL] [Abstract][Full Text] [Related]
14. Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.
Deo R; Fyr CL; Fried LF; Newman AB; Harris TB; Angleman S; Green C; Kritchevsky SB; Chertow GM; Cummings SR; Shlipak MG;
Am Heart J; 2008 Jan; 155(1):62-8. PubMed ID: 18082491
[TBL] [Abstract][Full Text] [Related]
15. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.
Ix JH; Shlipak MG; Chertow GM; Whooley MA
Circulation; 2007 Jan; 115(2):173-9. PubMed ID: 17190862
[TBL] [Abstract][Full Text] [Related]
16. Association Between Increased Levels of Cystatin C and the Development of Cardiovascular Events or Mortality: A Systematic Review and Meta-Analysis.
Einwoegerer CF; Domingueti CP
Arq Bras Cardiol; 2018 Dec; 111(6):796-807. PubMed ID: 30281693
[TBL] [Abstract][Full Text] [Related]
17. Serum cystatin C levels are associated with coronary artery disease and its severity.
Wang GN; Sun K; Hu DL; Wu HH; Wang XZ; Zhang JS
Clin Biochem; 2014 Nov; 47(16-17):176-81. PubMed ID: 25084128
[TBL] [Abstract][Full Text] [Related]
18. Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis.
Hoke M; Amighi J; Mlekusch W; Schlager O; Exner M; Sabeti S; Dick P; Koppensteiner R; Minar E; Rumpold H; Wagner O; Schillinger M
Stroke; 2010 Apr; 41(4):674-9. PubMed ID: 20150544
[TBL] [Abstract][Full Text] [Related]
19. Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome.
Ristiniemi N; Lund J; Tertti R; Christensson A; Ilva T; Porela P; Pulkki K; Pettersson K
Clin Biochem; 2012 May; 45(7-8):535-40. PubMed ID: 22394460
[TBL] [Abstract][Full Text] [Related]
20. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome.
Jernberg T; Lindahl B; James S; Larsson A; Hansson LO; Wallentin L
Circulation; 2004 Oct; 110(16):2342-8. PubMed ID: 15477399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
